Our Mission
Fearlessly pioneering novel therapies to make meaningful impact and provide hope for patients with fibrotic diseases.
Flavia Castelino, M.D.
Associate Professor of Medicine, Harvard Medical School, Division of Rheumatology, Massachusetts General Hospital
Lara Dimick-Santos, M.D.
Medical Director, CTI Clinical Trial & Consulting Services, former FDA medical reviewer
Scott Friedman, M.D.
Dean for Therapeutic Discovery, Fishberg Professor of Medicine, Director, Institute for Liver Research, Icahn School of Medicine at Mount Sinai
Robert Lafyatis, M.D.
Professor of Medicine, Division of Rheumatology & Clinical Immunology, University of Pittsburgh Medical Center
Rohit Loomba, M.D., MHSc
Professor of Medicine, Chief of the Division of Gastroenterology and Hepatology, University of California San Diego
Toby Maher, M.D., Ph.D.
Professor of Medicine, Director of Interstitial Lung Diseases, University of Southern California
Sydney Montesi, M.D.
Assistant Professor of Medicine, Harvard Medical School, Pulmonary and Critical Care Medicine, Massachusetts General Hospital
John Varga, M.D.
Professor of Medicine, Chief of the Division of Rheumatology, University of Michigan